As CEO of Rubius Therapeutics, Pablo Cagnoni oversees development of a type of cell therapy made with red blood cells, but he was at Novartis when that pharmaceutical giant struck the deal for the T cell research that proved to be a beacon for the cell therapy field. That CAR T therapy…
Source: medcitynews.com – Read more

Healthcare IT under siege: CloudWave is fighting back – SiliconANGLE
Healthcare IT under siege: CloudWave is fighting back SiliconANGLE

.webp?w=0&resize=0,0&ssl=1)
